Beijnen JH - Search Results

1

Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?

Kemper EM, Boogerd W, Thuis I, Beijnen JH, van Tellingen O. Kemper EM, et al. Among authors: beijnen jh. Cancer Treat Rev. 2004 Aug;30(5):415-23. doi: 10.1016/j.ctrv.2004.04.001. Cancer Treat Rev. 2004. PMID: 15245774 Review.

2

Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein.

Zaman GJ, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RP, Baas F, Borst P. Zaman GJ, et al. Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7690-4. doi: 10.1073/pnas.92.17.7690. Proc Natl Acad Sci U S A. 1995. PMID: 7644478 Free PMC article.

3

Entrapment by Cremophor EL decreases the absorption of paclitaxel from the gut.

Bardelmeijer HA, Ouwehand M, Malingré MM, Schellens J, Beijnen JH, van Tellingen O. Bardelmeijer HA, et al. Among authors: beijnen jh. Cancer Chemother Pharmacol. 2002 Feb;49(2):119-25. doi: 10.1007/s00280-001-0394-2. Epub 2001 Nov 20. Cancer Chemother Pharmacol. 2002. PMID: 11862425

4

Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir.

Bardelmeijer HA, Ouwehand M, Buckle T, Huisman MT, Schellens JH, Beijnen JH, van Tellingen O. Bardelmeijer HA, et al. Among authors: beijnen jh. Cancer Res. 2002 Nov 1;62(21):6158-64. Cancer Res. 2002. PMID: 12414642

5

Assessing safety and efficacy of directed P-glycoprotein inhibition to improve the pharmacokinetic properties of saquinavir coadministered with ritonavir.

Huisman MT, Smit JW, Wiltshire HR, Beijnen JH, Schinkel AH. Huisman MT, et al. Among authors: beijnen jh. J Pharmacol Exp Ther. 2003 Feb;304(2):596-602. doi: 10.1124/jpet.102.044388. J Pharmacol Exp Ther. 2003. PMID: 12538811

6

Metabolism of paclitaxel in mice.

Bardelmeijer HA, Oomen IA, Hillebrand MJ, Beijnen JH, Schellens JH, van Tellingen O. Bardelmeijer HA, et al. Among authors: beijnen jh. Anticancer Drugs. 2003 Mar;14(3):203-9. doi: 10.1097/00001813-200303000-00003. Anticancer Drugs. 2003. PMID: 12634614

7

Increased penetration of paclitaxel into the brain by inhibition of P-Glycoprotein.

Kemper EM, van Zandbergen AE, Cleypool C, Mos HA, Boogerd W, Beijnen JH, van Tellingen O. Kemper EM, et al. Among authors: beijnen jh. Clin Cancer Res. 2003 Jul;9(7):2849-55. Clin Cancer Res. 2003. PMID: 12855665

8

The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

van Herwaarden AE, Jonker JW, Wagenaar E, Brinkhuis RF, Schellens JH, Beijnen JH, Schinkel AH. van Herwaarden AE, et al. Among authors: beijnen jh. Cancer Res. 2003 Oct 1;63(19):6447-52. Cancer Res. 2003. PMID: 14559835

9

The influence of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) on the brain penetration of paclitaxel in mice.

Kemper EM, Cleypool C, Boogerd W, Beijnen JH, van Tellingen O. Kemper EM, et al. Among authors: beijnen jh. Cancer Chemother Pharmacol. 2004 Feb;53(2):173-8. doi: 10.1007/s00280-003-0720-y. Epub 2003 Nov 7. Cancer Chemother Pharmacol. 2004. PMID: 14605863

10

Development and validation of a method to determine the unbound paclitaxel fraction in human plasma.

van den Bongard HJ, Kemper EM, van Tellingen O, Rosing H, Mathôt RA, Schellens JH, Beijnen JH. van den Bongard HJ, et al. Among authors: beijnen jh. Anal Biochem. 2004 Jan 1;324(1):11-5. doi: 10.1016/j.ab.2003.07.024. Anal Biochem. 2004. PMID: 14654039

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,526 results

Search Page

Filters